MSAA News Update - Launch of Zeposia® (o... - My MSAA Community

My MSAA Community

9,019 members20,711 posts

MSAA News Update - Launch of Zeposia® (ozanimod) Announced

johnMSAA profile image
johnMSAAPartner
4 Replies

My MSAA Community members,

Please see info from MSAA on the recently-announced news of the commercial launch and availability of Zeposia® (ozanimod) for the treatment of adults with relapsing forms of multiple sclerosis - learn more in the Latest News link below:

mymsaa.org/news/launch-of-z...

Thank you!

- John, MSAA

Written by
johnMSAA profile image
johnMSAA
Partner
To view profiles and participate in discussions please or .
Read more about...
4 Replies
greaterexp profile image
greaterexp

Thank you for posting. Let's hope this is an important addition to treatment options.

Jesmcd2 profile image
Jesmcd2CommunityAmbassador

Hey another one for SPMS along with RMS! Hope it brings them closer to the cure!😁

rjoneslaw profile image
rjoneslaw

tanks for the info

Lilith08 profile image
Lilith08

I attended a virtual information session on this new drug just last week. It sounds promising. Has the usual long list of possible side effects, unfortunately; also unfortunately, I don't remember (m)any specifics—hahaha! I do know it was trialled against Avonex, though, and trial participants did better on Zeposia.

You may also like...

Another MSAA News Update - FDA Approves Mavenclad® (Cladribine) Tablets

Hello! The news updates keep coming! I just wanted to share the latest news update that MSAA has...

Webinar held through MSAA

doctor is having a webinar about MS through the MSAA wesite. Its called S.E.A.R.C.H. and its a 1hour

We are celebrating MSAA's 53rd Anniversary!

in commemorating MSAA'S 53rd anniversary! On June 8, 1970, the Multiple Sclerosis Association...

MSAA Wants to Hear from YOU!

Awareness Month and MSAA has several activities planned! We want to hear from our members – that...

I'm new to MSAA network

network. I discovered it in the fall issue of the MSAA magazine. I'm not sure how I received this...